Atopalm Acne Controlling

Product NDC: 51141-7000
11-digit product format: 511417000
Labeler code: 51141
Product ID: 51141-7000_7504a18f-1c22-4f87-95f3-97b65a9a9976
Type: HUMAN OTC DRUG
Nonproprietary name: SALICYLIC ACID
Dosage form: LOTION
Route: TOPICAL
Labeler: NeoPharm Co., Ltd.
Application: part333D
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2011-11-04
Marketing end: 0000-00-00
Substance: SALICYLIC ACID
Active strength: 2 mL/100mL
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	51141-7000		I	Inactivated by FDA		2026-10-05
excluded package	package	51141-7000	51141-7000-1	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	51141-7000-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	51141-7000-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51141-7000-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51141-7000-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51141-7000-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51141-7000-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51141-7000-1	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51141-7000-1	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51141-7000-1	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	51141-7000-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	51141-7000-1	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	51141-7000-1	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	51141-7000-1	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	51141-7000-1	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	51141-7000-1	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	51141-7000-1	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	51141-7000-1	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	51141-7000-1	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	51141-7000-1	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	51141-7000-1	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	51141-7000-1	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	51141-7000-1	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277	Product name	1	20190408
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
1681bc73-b05f-12c3-1075-382ae39f449c	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51141-7000-1	2019-11-13	C162847	48780-1	97449f38-cbf9-f6ea-e053-dbdaa90aa703	Atopalm Acne Controlling Lotion

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51141-7000-1	Atopalm Acne Controlling	1 in 1 CARTON	LOTION	1		2
51141-7000-1	Atopalm Acne Controlling	38.4 mL in 1 TUBE	LOTION	38.4		2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
ALLANTOIN	INACTIVE INGREDIENT	344S277G0Z	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
ARGININE	INACTIVE INGREDIENT	94ZLA3W45F	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
C13-14 ISOPARAFFIN	INACTIVE INGREDIENT	E4F12ROE70	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
CHOLESTEROL	INACTIVE INGREDIENT	97C5T2UQ7J	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
LAURETH-7	INACTIVE INGREDIENT	Z95S6G8201	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
MYRISTOYL/PALMITOYL OXOSTEARAMIDE/ARACHAMIDE MEA	INACTIVE INGREDIENT	1211AIM8G7	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
OCTYLDODECANOL	INACTIVE INGREDIENT	461N1O614Y	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600 KD)	INACTIVE INGREDIENT	0L414VCS5Y	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
POLYSORBATE 60	INACTIVE INGREDIENT	CAL22UVI4M	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51141-7000	ATOPALM ACNE CONTROLLING (SALICYLIC ACID) LOTION [NEOPHARM CO., LTD.]	2	Legacy NDC, 2 package rows	20111110_3049dca0-1ce5-4dee-95c0-b3563cbc511b.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
O414PZ4LPZ	SALICYLIC ACID	69-72-7	SALICYLIC ACID

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
103568	salicylic acid 2 % Topical Lotion	PSN	3049dca0-1ce5-4dee-95c0-b3563cbc511b	2
103568	salicylic acid 20 MG/ML Topical Lotion	SCD	3049dca0-1ce5-4dee-95c0-b3563cbc511b	2
103568	salicylic acid 2 % Topical Lotion	SY	3049dca0-1ce5-4dee-95c0-b3563cbc511b	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
51141-7000-1	51141700001	1 in 1 CARTON	Historical